Profound Medical Net Interest Income Over Time

PRN Stock  CAD 8.77  0.02  0.23%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Profound Medical Performance and Profound Medical Correlation.
  
As of the 8th of February 2026, Net Interest Income is likely to grow to about 1.7 M.
It's important to distinguish between Profound Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Profound Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Profound Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Specify up to 10 symbols:

Cross Equities Net Interest Income Analysis

Compare Profound Medical Corp and related stocks such as Berkshire Hathaway CDR, E L Financial, and Fairfax Financial Net Interest Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
20102011201220132014201520162017201820192020202120222023202420252026
BRK(3.9 B)(3.9 B)(3.9 B)(3.9 B)(3.9 B)(3.9 B)(3.9 B)(3.9 B)(3.9 B)(4 B)(4.1 B)(4.2 B)(4.4 B)(5 B)(5.2 B)(4.7 B)(4.9 B)
FFH(242.8 M)(242.8 M)(242.8 M)(242.8 M)(242.8 M)(242.8 M)(242.8 M)(331.2 M)(347.1 M)(472 M)(475.9 M)(513.9 M)(452.8 M)(510 M)(649 M)(584.1 M)(613.3 M)
SEC(14.5 M)(14.5 M)(14.5 M)(14.5 M)(14.5 M)(14.5 M)(14.5 M)(34 M)(20.2 M)(27.7 M)(10.6 M)(6.3 M)(23.5 M)(38 M)(37.3 M)(33.5 M)(35.2 M)

Profound Medical Corp and related stocks such as Berkshire Hathaway CDR, E L Financial, and Fairfax Financial Net Interest Income description

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

My Equities

My Current Equities and Potential Positions

Profound Medical Corp
PRN
ClassificationDrugs
Business Address2400 Skymark Avenue,
ExchangeToronto Exchange
CAD 8.77
When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:
Check out Profound Medical Performance and Profound Medical Correlation.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Profound Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Profound Medical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Profound Medical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...